)
Zhinan Xia
Founder & CSO,
Abimmune Bio
Zhinan Xia has more 25 years of Biopharma industrial experience and many years of CGT experience at Moderna, Dynamicure and Abimmune.
Sessions
-
24-Jun-2025Overcoming Barriers to Solid Tumor Treatment with TCR-T, NK Cells, and Macrophage-Based Approaches
-
23-Jun-2025Developability / manufacturability of bispecifics
-
18-Jun-2025Finding cancer-specific or cancer-enriched antigens that are not expressed on normal healthy tissues to avoid off-target toxicity
-
17-Jun-2025Developing strategies to modulate the TME by targeting immunosuppressive cells
-
04-May-2026Advancing mRNA-LNP gene therapy: overcoming challenges in manufacturing & QC process development